Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19282835rdf:typepubmed:Citationlld:pubmed
pubmed-article:19282835lifeskim:mentionsumls-concept:C0023418lld:lifeskim
pubmed-article:19282835lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:19282835lifeskim:mentionsumls-concept:C0927232lld:lifeskim
pubmed-article:19282835lifeskim:mentionsumls-concept:C0312738lld:lifeskim
pubmed-article:19282835lifeskim:mentionsumls-concept:C0035020lld:lifeskim
pubmed-article:19282835lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:19282835pubmed:issue8lld:pubmed
pubmed-article:19282835pubmed:dateCreated2009-8-12lld:pubmed
pubmed-article:19282835pubmed:abstractTextTo evaluate the impact of contemporary therapy on the clinical outcome of children with pre-B acute lymphoblastic leukemia (ALL) and the t(1;19)/TCF3/PBX1, we analyzed 735 patients with B-cell precursor ALL treated in four successive protocols at St Jude Children's Research Hospital. The 41 patients with the t(1;19) had a comparable event-free survival to that of the 694 patients with other B-cell precursor ALL (P=0.63; 84.2+/-7.1% (s.e.) vs 84.0+/-1.8% at 5 years). However, patients with the t(1;19) had a lower cumulative incidence of any hematological relapse (P=0.06; 0 vs 8.3+/-1.2% at 5 years) but a significantly higher incidence of central nervous system (CNS) relapse (P<0.001; 9.0+/-5.1% vs 1.0+/-0.4% at 5 years). In a multivariate analysis, the t(1;19) was an independent risk factor for isolated CNS relapse. These data suggest that with contemporary treatment, patients with the t(1;19) and TCF3/PBX1 fusion have a favorable overall outcome but increased risk of CNS relapse.lld:pubmed
pubmed-article:19282835pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:languageenglld:pubmed
pubmed-article:19282835pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:citationSubsetIMlld:pubmed
pubmed-article:19282835pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19282835pubmed:statusMEDLINElld:pubmed
pubmed-article:19282835pubmed:monthAuglld:pubmed
pubmed-article:19282835pubmed:issn1476-5551lld:pubmed
pubmed-article:19282835pubmed:authorpubmed-author:ChengCClld:pubmed
pubmed-article:19282835pubmed:authorpubmed-author:EvansW EWElld:pubmed
pubmed-article:19282835pubmed:authorpubmed-author:DowningJ RJRlld:pubmed
pubmed-article:19282835pubmed:authorpubmed-author:RaimondiS CSClld:pubmed
pubmed-article:19282835pubmed:authorpubmed-author:RibeiroR CRClld:pubmed
pubmed-article:19282835pubmed:authorpubmed-author:CampanaDDlld:pubmed
pubmed-article:19282835pubmed:authorpubmed-author:RellingM VMVlld:pubmed
pubmed-article:19282835pubmed:authorpubmed-author:SandlundJ TJTlld:pubmed
pubmed-article:19282835pubmed:authorpubmed-author:JehaSSlld:pubmed
pubmed-article:19282835pubmed:authorpubmed-author:PeiDDlld:pubmed
pubmed-article:19282835pubmed:authorpubmed-author:HowardS CSClld:pubmed
pubmed-article:19282835pubmed:authorpubmed-author:RubnitzJ EJElld:pubmed
pubmed-article:19282835pubmed:authorpubmed-author:OnciuMMlld:pubmed
pubmed-article:19282835pubmed:authorpubmed-author:PuiC-HCHlld:pubmed
pubmed-article:19282835pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19282835pubmed:volume23lld:pubmed
pubmed-article:19282835pubmed:ownerNLMlld:pubmed
pubmed-article:19282835pubmed:authorsCompleteYlld:pubmed
pubmed-article:19282835pubmed:pagination1406-9lld:pubmed
pubmed-article:19282835pubmed:dateRevised2011-2-24lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:meshHeadingpubmed-meshheading:19282835...lld:pubmed
pubmed-article:19282835pubmed:year2009lld:pubmed
pubmed-article:19282835pubmed:articleTitleIncreased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1.lld:pubmed
pubmed-article:19282835pubmed:affiliationDepartment of Oncology, St Jude Children's Research Hospital, Memphis, TN 38105, USA.lld:pubmed
pubmed-article:19282835pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19282835pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:19282835pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19282835lld:pubmed